Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > comparing potential partners?

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Nov 09, 2022 4:22pm

126 Views

Post# 35086500

RE:RE:RE:RE:RE:RE:comparing potential partners?

just curious which posters said aware data was not going to happen q4. My comment was bracelet had been pushed and confirmed by Westcoast on the boards and now u are changing this to aware 1 data. Do u have access to earlier presentations to see if guidance has always been the same for bracelet.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"